Linda Yaccarino, who just left Elon Musk's X, has a new job
Yaccarino on Tuesday was named the CEO of eMed, a Miami-based telehealth company that dispenses GLP-1 medications such as Wegovy and Ozempic.
The appointment marks a shift for Yaccarino, who has a background largely in marketing, advertising and media world. Prior to joining X, Yaccarino worked in various advertising and global partnerships for NBCUniversal and Turner for several decades.
In a press release, eMed said that Yaccarino is arriving in a 'game-changing moment' in the company's five-year old history, which is to 'make safe, effective and sustainable chronic care accessible directly through an all-in-one, digital-first experience.' The company added that her experience would be 'instrumental' as it looks to accommodate more 'national and global employer and government partnerships.'
'The healthcare industry has been disrupted by technology, but not yet completely transformed by it,' Yaccarino said in a press release. 'There is an opportunity to combine technology, lifestyle, and data in a new powerful way through the digital channels that impact consumers directly in ways that have never been done before.'
EMed got its start during the height of the pandemic in 2020, offering Covid tests and services. However, it has since pivoted to weight loss drugs, joining Weight Watchers, which recently exited bankruptcy and is forging a similar path of selling GLP-1 drugs online.
Yaccarino didn't immediately respond to CNN's request for comment.
She joined X, then called Twitter, in June 2023, which was about eight months after Musk bought the social media platform. Her main task was to help fix the platform's flagging advertising business, after the billionaire alienated brands with his controversial comments and changes to the platform.
But her tenure had been marked by repeated public relations crises, including scrutiny over antisemitic and other hateful content spreading on the platform, viral false claims around international conflicts and ads that appeared alongside pro-Nazi content on the site. That led some brands to pull their spending, for which the Yaccarino-led X sued an advertising industry group — a lawsuit Yaccarino announced in a video message to all X users, in which she decried what she referred to as a conspiracy to boycott the X platform. (The industry group, Global Alliance for Responsible Media, shut down days after the lawsuit was filed.)
A day before she announced her departure, the company's Grok chatbot began pushing antisemitic tropes in responses to users, however it wasn't clear that her exit was connected to that incident. The company later apologized.
CNN's Clare Duffy contributed to this report.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
2 minutes ago
- New York Times
Charleston's Climate Lawsuit Against Oil Giants Is Dismissed
A judge in Charleston, S.C., dismissed on Wednesday the city's lawsuit against oil and gas companies over their role in climate change, ruling that the case raised questions that were far beyond the bounds of state laws. During two days of hearings in May, lawyers for the city argued that the companies, ranging from giants like Exxon Mobil and Chevron to local firms, had covered up what they knew about the dangers of greenhouse gas emissions. They accused the companies of mounting a disinformation campaign to cast doubt on climate science and failing to warn the public about the dangers ahead. Those actions increased demand for fossil fuels, which led to emissions and the grave risks linked to climate change that the historic coastal city now faces, including flooding and sea-level rise, they argued. The case cited state tort laws and the state's Unfair Trade Practices Act and sought funds for adaptation and mitigation projects. In his 45-page decision, Judge Roger M. Young wrote that while the lawyers argued the claims were about deception, 'they are premised on, and seek redress for, the effects of greenhouse gas emissions.' He said that those issues fall squarely under federal and not state law, and that the court lacked jurisdiction over out-of-state companies. He cited a 2021 decision by the U.S. Court of Appeals for the Second Circuit in a similar lawsuit filed by New York City against oil companies. In that case, Judge Richard J. Sullivan of the Circuit Court addressed whether the municipalities could use state tort laws to hold multinational companies liable for damages caused by greenhouse gas emissions. 'Given the nature of the harm and the existence of a complex web of federal and international environmental law regulating such emissions, we hold that the answer is 'no,'' Judge Sullivan wrote. Want all of The Times? Subscribe.
CBS News
2 minutes ago
- CBS News
Long Island's historic Oheka Castle files for bankruptcy
Long Island's historic Oheka Castle estate has filed for bankruptcy. With its lush gardens, fountain and European ambiance, the 443-acre French-style chateau has been the backdrop for magical moments including weddings, movie shoots, music videos and more. It's listed on the National Register of Historic Places and Historic Hotels of America. "The name itself comes from Otto Herman Kahn. He was the original builder of the castle. It was one of his six summer homes," hotel manager Steven Kessler said. It has a rich history, which is all part of its charm. "We became a retreat for sanitation workers from the New York City Department of Sanitation. We also were a school for radio operators in World War II. The last thing we were was Eastern Military Academy," Kessler said. But the historic treasure, which is also the second largest private estate in the country, is facing financial trouble. Its owner Gary Melius filed for Chapter 11 bankruptcy. According to court documents, the property owes more than $60 million to creditors. "Right now, it's really just restructuring of pre-existing debt," Kessler said. Oheka Castle hosts over 200 events every year - most of them weddings. Kessler said that will not change. "You can come here for dinner, anniversary, luxury weddings," Kessler said. "We are open for business. We have all of our events for 2025-2026. Everything is still happening." Ashley Pastore got married at Oheka Castle in 2023. "It's every girl's dream to get married at Oheka Castle," she said. "Any excuse we have to go back, we go." New Yorkers say it's a staple on Long Island, and they want to see it preserved for generations to come - everything from its grand staircase to its formal gardens. "You could walk into that venue and not need anything. It's extraordinary. You could get married there and not put one decoration up. It's history itself," Pastore said. "We're always trying to preserve a piece of Gold Coast history, so that others can come and visit us, and experience what it was like to be in the Gatsby era," Kessler said. Mansion tours are also still available.
CBS News
2 minutes ago
- CBS News
Minnesota sees sedative overdose spike: "Naloxone isn't going to help"
By WCCO reporter Ashley Grams The Minnesota Department of Health issued a health advisory last week warning of an increase in overdose cases involving sedatives. Data collected by the department's Minnesota Drug Overdose and Substance Use Surveillance Activity (MNDOSA) project shows just one overdose case where the sedative xylazine was detected. That number jumped to 53 in 2024. Now, the state is tracking another sedative emerging in the drug supply. "Medetomidine, it has been seen in other parts of the country," said Deepa McGriff, the department's epidemiologist supervisor. "It is a veterinary sedative that's not approved for human use, and in 2025 we started to see more detections." The state's Public Health Laboratory started tracking medetomidine in 2024 and this year has seen 12 cases. "Here in Minnesota, we are somewhat insulated, initially, from new substances as they emerge, maybe on the East Coast or West Coast," said Jason Peterson, who supervises the chemical threats and bio monitoring units at the Public Health Laboratory. Peterson says medetomidine was "starting to grow" out on the East Coast. "They do take delays in a lot of times in entering our state, but we are mindful of that and we are mindful of the patterns where drugs typically flow across the country," he said. This increase in sedatives is a dangerous reality for drug users across the state. "Certainly for the subset of people that we work with that are using substances, we do see these things come through," said John Tribbett, the service area director for Avivo's ending homelessness division. "We are at a point unfortunately where you never know what people are getting, and what they end up putting in their body. Tribbett said all of Avivo's teams are trained in overdose reversal. The state's health advisory warns that these sedatives "significantly complicates the treatment of overdose patients." McGriff says the department wants the community and first responders to understand that sedatives may be a factor in an overdose, and how that can impact treatment. "If there's a sedative involved, the Naloxone isn't going to work to reverse that unresponsiveness," McGriff said. "We want to emphasize the need to focus on restoring the breathing of the overdose patients, rather than restoring the consciousness." McGriff said an opioid reversal drug like naloxone should still be used in these cases. Tribbett believes the emergence of medetomidine is a reflection of policy aimed at restricting xylazine. "What we see time and time again is a crackdown on one particular chemical, and then something emerges to replace it," Tribbett said. Some states have made an effort to limit access to xylazine in recent years, including Pennsylvania, which classified xylazine as a Schedule 3 drug. Minnesota's health department says data is still limited when it comes to medetomidine, but awareness is important — something Tribbett agrees with. "Making people aware, helping our teams have the information they need, helping people in the community know what's out there," Tribbett said.
